Last $4.35 USD
Change Today +0.02 / 0.46%
Volume 65.4K
QLTI On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ GS
Frankfurt
As of 2:51 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

qlt inc (QLTI) Snapshot

Open
$4.30
Previous Close
$4.33
Day High
$4.39
Day Low
$4.30
52 Week High
01/30/14 - $7.09
52 Week Low
12/16/14 - $3.35
Market Cap
222.7M
Average Volume 10 Days
121.8K
EPS TTM
--
Shares Outstanding
51.2M
EX-Date
06/28/13
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for QLT INC (QLTI)

qlt inc (QLTI) Related Businessweek News

No Related Businessweek News Found

qlt inc (QLTI) Details

QLT Inc., a biotechnology company, develops and commercializes ocular products that address the unmet medical needs of patients and clinicians worldwide. It focuses on the development of QLT091001, a synthetic retinoid compound, which is in phase Ib retreatment clinical trials for the treatment of leber congenital amaurosis and retinitis pigmentosa; phase Ib clinical trials for the treatment of Retinitis Pigmentosa with autosomal dominant mutation in RPE65; and phase IIa clinical trials for the treatment of impaired dark adaptation. The company was founded in 1981 and is headquartered in Vancouver, Canada.

37 Employees
Last Reported Date: 08/4/14
Founded in 1981

qlt inc (QLTI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

qlt inc (QLTI) Key Developments

QLT Inc. Announces Executive Changes

On January 5, 2015, QLT Inc. announced that its Board of Directors had appointed Glen Ibbott as Vice President, Finance of the company effective January 5, 2015 and as Interim Chief Financial Officer of the company effective January 26, 2015. Sukhi Jagpal's resignation as Chief Financial Officer of the company will become effective on January 26, 2015. Mr. Ibbott has held senior finance positions with multiple U.S. and Canadian exchange-listed pharmaceutical and biotechnology companies. From 2010 through August 2014, Mr. Ibbott served as Vice President of Finance (and CFO of Targeted Therapies) at Nordion Inc. From 2008 to 2010, Mr. Ibbott served as Corporate Controller of International Forest Products Ltd.

QLT Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

QLT Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

QLT Inc.(NasdaqGS:QLTI) added to NASDAQ Biotechnology Index

QLT Inc. will be added to the NASDAQ Biotechnology Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QLTI:US $4.35 USD +0.02

QLTI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for QLTI.
View Industry Companies
 

Industry Analysis

QLTI

Industry Average

Valuation QLTI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QLT INC, please visit www.qltinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.